Executive Summary
FieldProof™ is the test‑market validation layer that closes the gap between campaigns approved in conference rooms and campaigns proven in the communities they are supposed to move. Instead of validating big bets through focus groups, internal creative reviews, and convenience test markets, FieldProof™ pairs online psychographic surveying with Claritas® PRIZM geographic density mapping to test finished campaigns in archetype‑dense ZIP codes before system‑wide activation commits.
Over a single engagement, FieldProof™ reconciles your BrandCore™ archetype profile with Claritas® density data, calibrates audience size and minimum media thresholds, and executes closed‑system test‑market media through SBCMO Health Architecture and its media partner under De‑Risked or Accelerated paths, delivering decision‑ready resonance and performance evidence by archetype cluster. The result is a renewable, five‑year validation asset that lets health systems de‑risk multi‑market launches, reallocate spend before roll‑out, and answer the board’s question—“How do we know this will work where we’re spending?”—with statistically defensible proof instead of post‑mortem explanations.
Product Detail
How It Works
FieldProof™ is delivered as an integrated test market validation engagement structured around the BrandCore™ archetype foundation, the online psychographic survey toolchain, the Claritas® PRIZM geographic density layer, and SBCMO's closed-system test market execution. The output is decision-ready validation evidence; system-wide activation deploys through BrandLaunchHC™ or your existing campaign infrastructure after FieldProof™ concludes. Path selection—De-Risked or Accelerated—is determined at engagement initiation based on validation scope and market footprint.
Archetype Foundation Reconciliation
Every FieldProof™ engagement begins with the BrandCore™ archetype profile of the catchment zones in scope. Where BrandCore™ has not been previously fielded, it is run as part of the FieldProof™ engagement; where it exists, the existing profile feeds the validation strategy directly.
Claritas® PRIZM Geographic Density Mapping
Claritas® PRIZM data is deployed against the archetype profile to identify the ZIP codes and catchment zones with the highest concentration of each target archetype. Test markets are selected by archetypal density—not by geographic convenience, historical familiarity, or media rep recommendation.
Audience Sizing and Market Investment
Statistically valid test market validation requires sufficient reach and frequency to produce defensible data. SBCMO sizes the archetype-aligned audience in each test market against published reach-and-frequency thresholds for psychographic validation and establishes a minimum media investment that ensures the validation produces evidence the activation engagement can defend. Below the minimum threshold, validation results are statistically thin; the minimum is a methodological floor, not a sales target.
WORKED EXAMPLE—Reach and Frequency Calibration
Consider a regional health system test market:
Total catchment zone population: 420,000 adults 25–64
Archetype-density threshold (top-quartile PRIZM ZIPs): 28% of catchment
Archetype-aligned addressable audience: ~117,600 adults
SBCMO targets an effective frequency of 3+ exposures within the test window—anchored in the Krugman three-exposure threshold and the Ostrow Model for message-recall validity:
Target effective reach (3+): 65% of archetype-aligned audience
Effective reach in absolute terms: ~76,400 archetype-aligned adults at 3+ frequency
Average frequency required (Ostrow-adjusted): ~5.2
Gross impressions required: ~76,400 × 5.2 = ~397,000 impressions
The gross impression requirement is the mathematical output of the reach-and-frequency model. Translating that output to actual market investment requires calibration against the variables FieldProof™ operates within—healthcare advertising inventory costs, multi-channel deployment requirements, psychographic targeting depth premiums, and competitive market intensity. Those variables are captured in the market investment floors below.
Market Investment Floors
These figures represent media pass-through costs—separate from the FieldProof™ engagement fee, invoiced at actual cost plus a 10% coordination fee, and transparently disclosed at scoping. They account for inventory competition, psychographic targeting premiums, cross-channel deployment across programmatic, social, and connected television, and message-variant count. Exact media investment is calibrated at scoping against the actual catchment zone, archetype density, message-variant count, and validation-confidence threshold.
The minimum is the math, not the markup.
Why FieldProof™ Operates as a Closed System
FieldProof™ test market media execution runs through SBCMO and its media partner—not through external agencies—for four methodologically necessary reasons:
Protocol fidelity. SBCMO's archetypal targeting protocols, geo-fencing precision, frequency capping, and creative rotation standards are calibrated to produce statistically defensible validation evidence. External media execution against generic performance benchmarks compromises validity.
Optimization authority. Mid-test optimization decisions—whether to extend, recalibrate, or terminate a test market—require the team that understands the archetypal hypothesis, not external media buyers operating against generic KPIs.
Methodological IP integrity. The archetype-aligned targeting layer is SBCMO's proprietary methodology. Test market execution keeps that methodology inside the closed system that produced it.
Commercial alignment. SBCMO captures a 10% media coordination fee on the test market spend, transparently disclosed at scoping. The fee aligns SBCMO's incentive with validation success—SBCMO is compensated to make the test work, not to deliver a report regardless of outcome.
System-wide activation—full media buying across all facilities post-validation—deploys through BrandLaunchHC™ or your existing media partner, agency-of-record, or in-house team. The closed-system requirement applies only to test market execution.
Online Psychographic Survey Deployment
Campaign messages—finished creative, message variants, narrative frames, or pre-creative concept tests—are deployed through an online psychographic survey platform against the archetype-aligned audience segments identified through Claritas® PRIZM and reached through the closed-system test market execution. The survey instrument captures resonance, recall, attitudinal lift, and behavioral intent shifts segmented by archetype. The output is not "did the campaign perform?" but "which archetype clusters did it move, by how much, and which clusters did it miss?"
Path Selection—De-Risked or Accelerated
FieldProof™ delivers in two structured test market paths calibrated to budget, urgency, and engagement scope:
De-Risked Path ($45,000–$65,000)—Comprehensive test market validation across multi-market deployments, multi-message creative testing, full archetype-cluster coverage, and pre-activation optimization rounds. Designed for systems where the cost of a misfire across the full activation footprint is materially larger than the cost of comprehensive validation.
Accelerated Path ($30,000–$40,000)—Rapid test market confirmation structured for single-market or limited-market deployments where the campaign architecture is largely set and validation is confirming archetypal resonance before activation. Faster, focused, and structurally efficient.
Both paths include the closed-system test market execution architecture; the breadth of validation scope and depth of cross-market synthesis differ between paths.
Cross-Market Archetype Cluster Synthesis
For multi-facility engagements, archetype clusters identified across test markets are synthesized into a system-wide validation intelligence layer. Cross-market patterns are surfaced; market-specific deviations are named; the validation strategy compounds rather than restarts at every facility. Every market benefits from what every other test market learns.
Validation Reporting and Activation Handoff
Test market validation outputs are delivered as decision-ready intelligence: which messages move which archetype clusters, where the geographic density supports activation, and where archetype-aligned messaging requires recalibration before system-wide launch. The report is structured for executive decision-making, not analyst interpretation.
FieldProof™ outputs deploy alongside BrandCore™ archetype foundations, BrandLaunchHC™ activation architecture, and MissionAtlasHC™ enterprise platforms. The validation evidence reads against the same archetype profile that powers the rest of the SBCMO suite; the activation strategy operates on the same source of truth as the brand strategy. System-wide activation—full media buying across all facilities, creative production at scale, and campaign execution beyond the test markets—deploys through BrandLaunchHC™ or your existing media partner, agency-of-record, or in-house team. FieldProof™ owns test market execution end-to-end; the system-wide rollout is outside the FieldProof™ engagement scope.
Who It's For
- Chief Marketing Officers and VPs of Marketing at health systems preparing major campaign launches—service-line introductions, brand refreshes, market-entry campaigns—where the cost of a system-wide misfire is materially larger than the cost of test market validation
- Health systems with 10 or more facilities planning multi-market activation, where SBCMO's methodological standard requires controlled test market validation before system-wide deployment commits
- Health systems with 20+ facilities planning parallel multi-market activation, where sequential market testing would compound delay across the system and cross-market validation synthesis is structurally required
- CMOs supporting brand refreshes that have already passed internal creative approval but have not yet been confirmed against the community the campaign is being asked to move—where the validation gap is the difference between a board-defended strategy and a board-questioned outcome
- Health systems whose previous campaigns have underperformed in specific markets without an explanation the volume math could produce—and the executive team recognizes that demographic targeting was the variable, not creative quality
- Health systems whose internal validation infrastructure is built on focus groups, creative reviews, and brand intuition—and the executive team wants live test market psychographic evidence—captured under controlled execution conditions—before activation budget commits
- If the question "how do we know this campaign will work in the markets we're spending in?" is showing up before launch—not after—FieldProof™ is the test market validation layer the existing infrastructure is missing.
Use Case
Scenario: A 22‑facility regional health system preparing a system‑wide brand refresh engages FieldProof™ on the De‑Risked Path after internal creative review approves a campaign architecture the brand team is confident will resonate. Claritas® PRIZM mapping identifies that the campaign’s strongest creative variant is being deployed primarily into ZIP codes where the target archetype is under‑represented—and a secondary creative variant the internal team had nearly cut is archetypally aligned with the densest concentrations of the target audience. SBCMO and its media partner execute the controlled test market buy across four archetype‑density‑aligned markets at the calculated reach‑and‑frequency floor. The online psychographic survey validation confirms the recalibration: the secondary variant outperforms the primary by a material margin in the high‑density zones, while the primary holds parity in the secondary markets. The system reallocates media weight before the system‑wide activation launches. Campaign performance lands materially above benchmark across the 22 facilities; two markets that have historically underperformed against system averages close the gap entirely.
What You Own
Every FieldProof™ engagement transfers permanent IP to the client: the catchment-zone archetype profile (where deployed as part of the engagement), the Claritas® PRIZM geographic density map, the audience sizing and reach-and-frequency calibration, the online psychographic survey validation outputs and segmented resonance data, the Cross-Market Archetype Cluster Synthesis (where in scope), and the Validation Reporting and Activation Handoff package—strategically valid and independently deployable for a minimum of five years, with no continued relationship with SBCMO required. Our methodology, the archetypal targeting protocols, and the closed-system execution architecture remain proprietary; the test market validation evidence and the geographic intelligence the engagement produces are yours.
What's Included
- Archetype Foundation Reconciliation against BrandCore™ profile
- Claritas® PRIZM geographic density mapping per archetype cluster in scope
- Audience sizing and minimum test market media investment calibration against reach-and-frequency thresholds for statistical validity
- Closed-system test market media execution through SBCMO and its media partner—protocol fidelity, optimization authority, and IP integrity controlled end-to-end
- Online psychographic survey deployment with archetype-segmented resonance reporting
- De-Risked or Accelerated test market path delivery as elected at engagement initiation
- Cross-Market Archetype Cluster Synthesis (multi-facility engagements)
- Validation Reporting and Activation Handoff package
- Integrated intelligence handoff to BrandCore™, BrandLaunchHC™, and MissionAtlasHC™
- Permanent IP transfer of all maps, calibrations, validation outputs, and synthesis frameworks
- Transparent third-party pass-through pricing on online psychographic survey platform, Claritas®, and test market media coordination (vendor cost plus 10% coordination fee)
What's Not Included
- System-wide media buying across all facilities post-validation—FieldProof™ executes test market media as a closed system through SBCMO and its media partner; the system-wide activation that follows deploys through BrandLaunchHC™ or your existing media partner, agency-of-record, or in-house team. The closed-system requirement applies only to test market execution; system-wide rollout is outside FieldProof™ scope and budget
- Creative production, finished asset development, or campaign content authoring—handled by your existing creative team or production partner; FieldProof™ tests the creative under controlled execution conditions, it does not produce it
- Post-launch campaign optimization, performance tracking, or attribution measurement on the system-wide activation—handled by your existing media analytics partner or in-house team; FieldProof™ produces the pre-activation test market validation under controlled conditions, not the post-launch system-wide measurement
- Online survey platform or Claritas® licensing as standalone subscriptions—clients who already license either tool can apply existing data to the engagement scope; otherwise, costs flow through transparently per the published pass-through pricing
- Survey fielding cost overruns beyond engagement scope—addressed at engagement initiation; scope changes mid-engagement are addressed transparently before incremental cost commits
- Custom panel construction beyond the survey platform's standard psychographic infrastructure—available as a scoped enhancement where required; not included in standard engagement scope
- Test markets executed through external media agencies—incompatible with the closed-system methodology; FieldProof™ engagements that require test market execution must use SBCMO and its media partner to preserve protocol fidelity and validation integrity